Paclitaxel Partitioning into Lipid Bilayers
- 29 February 1996
- journal article
- Published by American Geophysical Union (AGU) in Journal of Pharmaceutical Sciences
- Vol. 85 (2) , 228-231
- https://doi.org/10.1021/js950120i
Abstract
Paclitaxel (taxol) is diterpenoid anticancer drug with a new mechanism of cytostatic action. It is under investigation in clinical trials for treatment of various types of human cancer. A major difficulty in developing paclitaxel as a chemotherapeutic agent in its poor water solubility. In order to improve the bioavailability of paclitaxel, novel vehicle systems such as mixed micelles or liposome-based formulations are being developed. In this study we determined the partition coefficient of paclitaxel partitioning into small unilamellar lipid vesicles composed of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine using two different methods, namely high-sensitivity titration calorimetry and fluorescence spectrometry. We measured a partition coefficient of Kp approximately equal to 9,500 M-1, a partition enthalpy of Delta H = -25 +/- 3 kcal mol-1 and a free energy of binding of Delta G = -7.9 kcal mol-1. The binding reaction is enthalpy-driven, which can be explained by van der Waals interactions between the hydrophobic drug and the strong temperature dependence of the partition equilibrium. A temperature increase of 10 degrees C reduces the paclitaxel solubility in the lipid phase by a factor of 4.Keywords
This publication has 25 references indexed in Scilit:
- Taxol-Lipid Interactions: Taxol-Dependent Effects on the Physical Properties of Model MembranesBiochemistry, 1994
- Novel Taxol Formulations: Preparation and Characterization of Taxol-Containing LiposomesPharmaceutical Research, 1994
- A Mixed Micellar Formulation Suitable for the Parenteral Administration of TaxolPharmaceutical Research, 1994
- Synthesis and evaluation of some water-soluble prodrugs and derivatives of taxol with antitumor activityJournal of Medicinal Chemistry, 1992
- Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast CancerJNCI Journal of the National Cancer Institute, 1991
- Studies With RP 56976 (Taxotere): A Semisynthetic Analogue of TaxolJNCI Journal of the National Cancer Institute, 1991
- Rapid measurement of binding constants and heats of binding using a new titration calorimeterAnalytical Biochemistry, 1989
- Taxol stabilizes microtubules in mouse fibroblast cells.Proceedings of the National Academy of Sciences, 1980
- Histamine release in dogs by Cremophor El® and its derivatives: Oxethylated oleic acid is the most effective constituentInflammation Research, 1977
- Plant antitumor agents. VI. Isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifoliaJournal of the American Chemical Society, 1971